慢性肠衰竭病人的营养治疗和药物治疗

摘要/Abstract

中图分类号:

R459.3

高学金, 王新颖. 慢性肠衰竭病人的营养治疗和药物治疗[J]. 外科理论与实践, 2020, 25(02): 159-162.

GAO Xuejin, WANG Xinying. Nutrition support and pharmacologic management in patients with chronic intestinal failure[J]. Journal of Surgery Concepts & Practice, 2020, 25(02): 159-162.

参考文献36

[1]	Irving M. Ethical problems associated with the treatment of intestinal failure[J]. Aust N Z J Surg, 1986, 56(5):425-427. doi:10.1111/j.1445-2197.1986.tb02345.x URL
[2]	Pironi L, Arends J, Baxter J, et al. ESPEN endorsed re-commendations. Definition and classification of intestinal failure in adults[J]. Clin Nutr, 2015, 34(2):171-180. doi:10.1016/j.clnu.2014.08.017pmid:25311444
[3]	Pironi L, Corcos O, Forbes A, et al. Intestinal failure in adults: Recommendations from the ESPEN expert groups[J]. Clin Nutr, 2018, 37(6 Pt A):1798-1809. doi:S0261-5614(18)31253-6pmid:30172658
[4]	Brandt CF, Hvistendahl M, Naimi RM, et al. Home pa-renteral nutrition in adult patients with chronic intestinal failure: the evolution over 4 decades in a tertiary referral center[J]. J Parenter Enteral Nutr, 2017, 41(7):1178-1187. doi:10.1177/0148607116655449 URL
[5]	Pironi L, Konrad D, Brandt C, et al. Clinical classification of adult patients with chronic intestinal failure due to benign disease: an international multicenter cross-sectional survey[J]. Clin Nutr, 2018, 37(2):728-738. doi:S0261-5614(17)30152-8pmid:28483328
[6]	毛琦, 李幼生, 黎介寿, 等. 中国短肠综合征诊疗共识(2016年版,南京)[J]. 中华胃肠外科杂志, 2017, 20(1):1-8.
[7]	Jeppesen PB. Spectrum of short bowel syndrome in adults: intestinal insufficiency to intestinal failure[J]. J Parenter Enteral Nutr, 2014, 38(1 Suppl):8S-13S. doi:10.1177/0148607114520994 URL
[8]	Bharadwaj S, Tandon P, Rivas JM, et al. Update on the management of intestinal failure[J]. Cleve Clin J Med, 2016, 83(11):841-848. doi:10.3949/ccjm.83a.15045 URL
[9]	Buchman AL. Etiology and initial management of short bowel syndrome[J]. Gastroenterology, 2006, 130(2 Suppl 1):S5-S15. doi:10.1053/j.gastro.2005.07.063pmid:16473072
[10]	Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation[J]. Gastroenterology, 2003, 124(4):1111-1134. pmid:12671904
[11]	Duggan CP, Jaksic T. Pediatric intestinal failure[J]. N Engl J Med, 2017, 377(7):666-675. doi:10.1056/NEJMra1602650 URL
[12]	Joly F, Mayeur C, Messing B, et al. Morphological adaptation with preserved proliferation/transporter content in the colon of patients with short bowel syndrome[J]. Am J Physiol Gastrointest Liver Physiol, 2009, 297(1):G116-G123. doi:10.1152/ajpgi.90657.2008 URL
[13]	Billiauws L, Maggiori L, Joly F, et al. Medical and surgical management of short bowel syndrome[J]. J Visc Surg, 2018, 155(4):283-291. doi:S1878-7886(17)30182-0pmid:30041905
[14]	Crenn P, Morin MC, Joly F, et al. Net digestive absorption and adaptive hyperphagia in adult short bowel patients[J]. Gut, 2004, 53(9):1279-1286. pmid:15306586
[15]	Cosnes J, Lamy P, Beaugerie L, et al. Adaptive hyperphagia in patients with postsurgical malabsorption[J]. Gastroenterology, 1990, 99(6):1814-1819. pmid:2227296
[16]	Briet F, Flourié B, Achour L, et al. Bacterial adaptation in patients with short bowel and colon in continuity[J]. Gastroenterology, 1995, 109(5):1446-1453. pmid:7557124
[17]	Jeppesen PB, Hartmann B, Thulesen J, et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon[J]. Gut, 2000, 47(3):370-376. pmid:10940274
[18]	Martin G, Wallace L, Hartmann B, et al. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome[J]. Am J Physiol Gastrointest Liver Physiol, 2005, 288(3):G431-G438. doi:10.1152/ajpgi.00242.2004 URL
[19]	Nightingale JM, Kamm MA, van der Sijp JP, et al. Gastrointestinal hormones in short bowel syndrome. peptide YY may be the“colonic brake” to gastric emptying[J]. Gut, 1996, 39(2):267-272. pmid:8977342
[20]	李宁. 肠功能障碍的肠内营养策略[J]. 肠外与肠内营养. 2010, 17(4):193-194.
[21]	Wan X, Bi J, Gao X, et al. Partial enteral nutrition preserves elements of gut barrier function, including innate immunity, intestinal alkaline phosphatase (IAP) level, and intestinal microbiota in mice[J]. Nutrients, 2015, 7(8):6294-6312. doi:10.3390/nu7085288 URL
[22]	Pironi L, Arends J, Bozzetti F, et al. ESPEN guidelines on chronic intestinal failure in adults[J]. Clin Nutr, 2016, 35(2):247-307. doi:S0261-5614(16)00047-9pmid:26944585
[23]	Gianotti L, Alexander JW, Gennari R, et al. Oral glutamine decreases bacterial translocation and improves survival in experimental gut-origin sepsis[J]. J Parenter Enteral Nutr, 1995, 19(1):69-74. doi:10.1177/014860719501900169 URL
[24]	Byrne TA, Wilmore DW, Iyer K, et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial[J]. Ann Surg, 2005, 242(5):655-661.
[25]	Guo M, Li Y, Li J. Effect of growth hormone, glutamine, and enteral nutrition on intestinal adaptation in patients with short bowel syndrome[J]. Turk J Gastroenterol. 2013, 24(6):463-468. doi:10.4318/tjg.2013.0555 URL
[26]	Wang H, Hong T, Li N, et al. Soluble dietary fiber improves energy homeostasis in obese mice by remodeling the gut microbiota[J]. Biochem Biophys Res Commun, 2018, 498(1):146-151. doi:10.1016/j.bbrc.2018.02.017 URL
[27]	Billiauws L, Thomas M, Le-Beyec-Le-Bihan J, et al. Intestinal adaptation in short bowel syndrome. What is new?[J]. Nutr Hosp, 2018, 35(3):731-737. doi:10.20960/nh.1952pmid:29974785
[28]	Nordgaard I, Hansen BS, Mortensen PB. Colon as a digestive organ in patients with short bowel[J]. Lancet, 1994, 343(8894):373-376. pmid:7905549
[29]	Yang J, Sun H, Wan S, et al. Risk factors for nephrolithia-sis in adults with short bowel syndrome[J]. Ann Nutr Metab, 2019, 75(1):47-54. doi:10.1159/000502329 URL
[30]	Wang X, Tian F, Sun H, et al. Insulin-like growth factor-1 as a nutritional monitoring factor in patients with chronic intestinal failure[J]. Clin Nutr, 2019, 38(4):1737-1744. doi:10.1016/j.clnu.2018.07.031 URL
[31]	Kumpf VJ. Pharmacologic management of diarrhea in patients with short bowel syndrome[J]. J Parenter Enteral Nutr, 2014, 38(1 Suppl):38S-44S. doi:10.1177/0148607113520618 URL
[32]	Kim ES, Keam SJ. Teduglutide: a review in short bowel syndrome[J]. Drugs, 2017, 77(3):345-352. doi:10.1007/s40265-017-0703-7 URL
[33]	Sigalet DL, Lam V, Boctor D. The assessment, and glucagon-like peptide-2 modulation, of intestinal absorption and function[J]. Semin Pediatr Surg, 2010, 19(1):44-49. doi:10.1053/j.sempedsurg.2009.11.005pmid:20123273
[34]	Lam K, Schwartz L, Batisti J, et al. Single-center expe-rience with the use of teduglutide in adult patients with short bowel syndrome[J]. J Parenter Enteral Nutr, 2018, 42(1):225-230. doi:10.1002/jpen.1011 URL
[35]	Billiauws L, Bataille J, Boehm V, et al. Teduglutide for treatment of adult patients with short bowel syndrome[J]. Expert Opin Biol Ther, 2017, 17(5):623-632. doi:10.1080/14712598.2017.1304912pmid:28293969
[36]	Hvistendahl M, Brandt CF, Tribler S, et al. Effect of liraglutide treatment on jejunostomy output in patients with short bowel syndrome: an open-label pilot study[J]. J Parenter Enteral Nutr, 2018, 42(1):112-121. doi:10.1177/0148607116672265 URL

慢性肠衰竭病人的营养治疗和药物治疗

Nutrition support and pharmacologic management in patients with chronic intestinal failure

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献36

相关文章13

编辑推荐

Metrics

本文评价

[1]	施咏梅, 蒋咏梅, 罗茜, 金倩雯, 陈尔真.瑞金医院新型冠状病毒感染病人营养治疗建议（2023版）[J]. 外科理论与实践, 2023, 28(01): 49-52.
[2]	宣呈杰, 卞冬生, 蒋咏梅, 陈宇菲, 金佳斌, 施咏梅.营养治疗对减重术后身体成分及静息能量消耗的影响[J]. 外科理论与实践, 2022, 27(03): 244-248.
[3]	中华医学会肠外肠内营养学分会.新型冠状病毒肺炎重症病人的肠外肠内营养治疗专家建议[J]. 外科理论与实践, 2020, 25(01): 35-39.
[4]	许媛.危重症病人的营养管理[J]. 外科理论与实践, 2018, 23(01): 20-23.
[5]	吴国豪,.如何优化外科危重病人营养治疗的作用[J]. 外科理论与实践, 2014, 19(01): 6-8.
[6]	吴国豪,.恶性肿瘤病人恶病质发生机制及营养治疗[J]. 外科理论与实践, 2012, 17(02): 98-101.
[7]	.百普力~/百普素~危重病肠内营养治疗优秀论文征集活动[J]. 外科理论与实践, 2009, 14(03): 268-.
[8]	.百普力~/百普素~危重病肠内营养治疗优秀论文征集活动[J]. 外科理论与实践, 2009, 14(02): 134-.
[9]	万燕萍, 徐仁应,.非酒精性脂肪性肝病营养治疗[J]. 内科理论与实践, 2008, 3(01): 57-60.
[10]	周巧玲,.慢性肾脏病营养临床实践[J]. 内科理论与实践, 2007, 2(06): 405-407.
[11]	黎介寿,吴肇汉,曹伟新.营养与代谢(3)[J]. 外科理论与实践, 2002, 7(01): 83-90.
[12]	柳汉荣,花天放,孔令诚,钟福全.谷氨酰胺对短肠综合征大鼠残留小肠代偿作用的影响[J]. 外科理论与实践, 2000, 5(01): 21-23.
[13]	许剑民,靳大勇,谢建新,吴肇汉.肠内营养促短肠大鼠结肠代偿性增生[J]. 外科理论与实践, 2000, 5(01): 27-30.